Evidence map›Paper›PMID 34761008›Full record

ArticleJournal of immunology research2021

Protective Effect of Uric Acid on ox-LDL-Induced HUVECs Injury via Keap1-Nrf2-ARE Pathway.

Yajuan Lin, Yunpeng Xie, Zhujing Hao, Hailian Bi, Yang Liu, Xiaolei Yang, Yunlong Xia

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Protective Effect ofJournal of microbiology and biotechnology · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Serum Direct Bilirubin as a Biomarker for Breast Cancer.Breast cancer (Dove Medical Press) · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yajuan LinDepartment of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Yunpeng XieDepartment of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.ORCID https://orcid.org/0000-0002-0140-1055
Zhujing HaoDepartment of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Hailian BiDepartment of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Yang LiuDepartment of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Xiaolei YangDepartment of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.ORCID https://orcid.org/0000-0002-6132-5971
Yunlong XiaDepartment of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.ORCID https://orcid.org/0000-0001-7985-3273
Dalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Uric acid is an effective antioxidant. Oxidized low-density lipoprotein (ox-LDL) is derived from circulating LDL and promotes atherosclerosis. The Keap1-Nrf2-ARE pathway is a key body pathway involved in protection against internal and external oxidative damages. The role of uric acid on vascular endothelial function damaged by ox-LDL, and its effect on the Keap1-Nrf2-ARE pathway has not been fully explored. HUVECs were treated with different concentrations of uric acid and ox-LDL to explore the effect of uric acid in vitro. Cell phenotype was determined by cytometry and Western blot. Nuclear translocation of Nrf2 was determined by immunofluorescence. Coimmunoprecipitation was used to determine the level of Nrf2 ubiquitination. A microfluidic device was used to mimic the vascular environment in the body, and the level of mRNA levels of inflammatory factors was determined by RT-PCR. The findings of this study show that suitable uric acid can significantly reduce endothelial damage caused by ox-LDL, such as oxidative stress, inflammation, and increased adhesion. In addition, uric acid reduced Nrf2 ubiquitination and increased nuclear translocation of Nrf2 protein, thus activating the Keap1-Nrf2-ARE pathway and playing a protective role. Interestingly, the effects of UA were significantly inhibited by administration of Brusatol, an inhibitor of Nrf2. In summary, suitable concentrations of uric acid can alleviate the oxidative stress level of endothelial cells through Nrf2 nuclear translocation and further protect cells from damage.

Indexed as

AntioxidantsAtherosclerosisCarboxylic Ester HydrolasesCell AdhesionCell Line, TumorCells, CulturedHumansHuman Umbilical Vein Endothelial CellsInflammationKelch-Like ECH-Associated Protein 1Lipoproteins, LDLNF-E2-Related Factor 2Oxidative StressProtective AgentsSignal TransductionTHP-1 CellsAntioxidantsarylesteraseCarboxylic Ester HydrolasesKEAP1 protein, humanKelch-Like ECH-Associated Protein 1Lipoproteins, LDLNFE2L2 protein, humanNF-E2-Related Factor 2oxidized low density lipoproteinProtective AgentsUric Acid

Identifiers

PMID34761008
PMCPMC8575640
OpenAlexW3208045776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.